Remove 2028 Remove Ethics Remove Training
article thumbnail

European regulators prepare for AI in pharma

European Pharmaceutical Review

The workplan, which runs until 2028, will help the European medicines regulatory network (EMRN) embrace the opportunities of AI for personal productivity, automating processes and systems, increasing insights into data and supporting more robust decision-making to benefit public and animal health.

Pharma 105
article thumbnail

Improving Patient-Physician Interaction with AI-Enhanced Data

PM360

million by 2028. Concerns regarding data privacy, algorithm bias, and regulatory compliance must be addressed to ensure the ethical and responsible use of AI in healthcare. Moreover, integrating AI into existing workflows requires robust infrastructure, interoperability standards, and ongoing training for healthcare providers.